Farmers are constantly looking for better ways to care for our crops, protect our animals and keep our farms sustainable for ...

The weight-loss drug market is currently one of the fastest-growing therapeutic areas in the pharmaceutical industry, and Eli ...

Novel CRISPR-Cas9 treatments are proving effective in reversing disease for life. But ensuring their long-term safety will take years.

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

The FDA’s press release noted that the guidance supports development of an array of cell and gene therapy products, including ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

Researchers developed PRINCE, a small-molecule-controlled CRISPR system enabling precise, long-term regulation of gene editing.

Volatile macroeconomic events are magnified in life science and healthcare applications, which are capital intensive, long-term investments with associated regulatory, safety, and commercial risks.

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Dr. David Liu, pictured with former lab members Holly Rees ...

You’re reading Book Currents, a weekly column in which notable figures share what they’re reading. Sign up for the Goings On newsletter to receive their selections, and other cultural recommendations, ...